Phase I and pharmacokinetics study of a novel anti-CD20 antibody, RO5072759 (GA101), in Japanese patients (Pts) with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) pretreated with ...
New York, NY, Nov. 20, 2020 (GLOBE NEWSWIRE) -- IG Acquisition Corp. (NASDAQ: IGACU) (the “Company”) announced that, commencing November 23, 2020, holders of the units sold in the Company’s initial ...
better risk diversification, more trading opportunities, and tends to generate better outcomes. Traders in today's markets have a wide variety of asset classes to choose from, each with their own ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback